Abbott Laboratories Share Price Swiss Exchange
Equities
ABT
US0028241000
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
93 CHF | -.--% |
|
-.--% | -.--% |
Sales 2024 * | 41.72B 37.03B 3,480B | Sales 2025 * | 44.73B 39.7B 3,731B | Capitalization | 180B 160B 15,011B |
---|---|---|---|---|---|
Net income 2024 * | 5.98B 5.31B 499B | Net income 2025 * | 7.17B 6.36B 598B | EV / Sales 2024 * | 4.44 x |
Net Debt 2024 * | 5.47B 4.86B 456B | Net Debt 2025 * | 112M 99.48M 9.35B | EV / Sales 2025 * | 4.03 x |
P/E ratio 2024 * |
29.9
x | P/E ratio 2025 * |
25.8
x | Employees | 1,14,000 |
Yield 2024 * |
2.11% | Yield 2025 * |
2.27% | Free-Float | 86.96% |
Latest transcript on Abbott Laboratories
![Extreme 93](/images/extremecours_fleche.png)
![Extreme 93](/images/extremecours_fleche.png)
![Extreme 93](/images/extremecours_fleche.png)
![Extreme 89](/images/extremecours_fleche.png)
![Extreme 89](/images/extremecours_fleche.png)
![Extreme 70](/images/extremecours_fleche.png)
![Extreme 34.75](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | 01/15/01 |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 01/97/01 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 01/90/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Starks
BRD | Director/Board Member | 69 | 16/17/16 |
John Stratton
BRD | Director/Board Member | 63 | 29/17/29 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 09/11/09 |
Date | Price | Change |
---|---|---|
17/24/17 | 93 | -.--% |
14/24/14 | 93 | -.--% |
13/24/13 | 93 | -.--% |
12/24/12 | 93 | -.--% |
11/24/11 | 93 | -.--% |
Delayed Quote Swiss Exchange, February 19, 2024 at 10:01 pm IST
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.95% | 105B | |
-4.54% | 67.27B | |
-6.09% | 46.34B | |
+14.28% | 46.22B | |
+4.14% | 40.1B | |
+19.36% | 30.92B | |
-4.56% | 24.48B | |
+12.05% | 24.22B | |
-12.05% | 22.02B |
- Stock Market
- Equities
- ABT Stock
- ABT Stock